XBRU
GIMB
Market cap2.04bUSD
Oct 30, Last price
49.45EUR
1D
0.30%
1Q
10.75%
Jan 2017
-6.08%
Name
Gimv NV
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Gimv N.V. operates as an investment company, specializing in both direct private equity and venture capital placements, alongside committing capital to other funds. Its direct investment approach spans a comprehensive range of stages and financing structures. This includes supporting startups from seed, early, and mid-stages through to late venture and emerging growth, as well as engaging in pre-revenue, middle-market, and mature company investments. The firm facilitates buyouts, growth capital, public-to-private transactions, recapitalizations, and provides debt, shareholder loans, replacement capital, and bridge financing to small and medium-sized enterprises (SMEs). Through its fund of funds strategy, Gimv allocates capital to other venture capital and private equity vehicles. The firm targets high-potential growth companies capable of accelerating their expansion, often through a combination of organic development and strategic acquisitions. Gimv's investment focus is broad, encompassing sectors such as consumer goods and connected consumer technologies, R&D-intensive businesses positively impacting human health and the environment, automation, health and care, demographic shifts, financial services (including consumer digital lending), telecommunication services, marketing services, interactive home entertainment, smart industries, and sustainable urban development. Within its health and care platform, Gimv prioritizes companies poised for growth via internal expansion or a "buy-and-build" acquisition strategy. More specifically, the consumer vertical covers areas like consumer goods, various food categories (including healthy, prepared, and preserved), personal luxury items, home decor and building, household appliances, specialized housewares, travel and leisure, education, and sectors driven by digitalization and the digital economy. In the health and care arena, it targets life sciences, medical technology (medtech), healthcare services, veterinary pharmaceuticals, generic drugs, vaccines, diagnostic testing, and a range of medical devices and consumables. Its Smart Industries platform includes aerospace, energy transition, business-to-business (B2B) services, advanced engineering, and software solutions. The Sustainable Cities platform delves into infrastructure deployment, energy systems, recycling and recovery, transport and logistics, water purification, e-commerce, alternative energy sources, and energy-efficient infrastructure, as well as consumer-related services within these themes. Additionally, Gimv considers investments in building materials (including chemicals, fertilizers, and agricultural chemicals), mobility solutions, operational services, agricultural services, electronics, and heavy electrical equipment. Geographically, Gimv concentrates its efforts primarily within the DACH region (Austria, Germany, Switzerland), the Benelux countries, France, and the United Kingdom. It also has a presence in Italy, Luxembourg, the Netherlands, Russia, Kazakhstan, the Czech Republic, and Slovakia. Its investments target small and medium-sized enterprises (SMEs), predominantly those headquartered in the Benelux, France, and Germany. Investment amounts typically range from €5 million ($5.67 million) to €150 million ($170.22 million), primarily within its consumer, healthcare, smart industries, and sustainable cities platforms. Gimv is flexible regarding ownership, taking either majority or minority stakes in its portfolio companies. Established on February 25, 1980, Gimv N.V. is headquartered in Antwerp, Belgium, and maintains additional offices across Europe, including Paris (France), The Hague (Netherlands), Frankfurt am Main and Munich (Germany), London (United Kingdom), Prague (Czech Republic), and Warsaw (Poland).
Related entities
Subsidiaries (9)
Adviesbeheer Gimv Connected Consumer 2013
ADVIESBEHEER GIMV HEALTH & CARE 2013
ALRO
ALRO HOLDINGS
CODEX 324 HOLDING
Gimv Investments H&C Netherlands 2016 B.V.
ACCEO GROUP
FT IMMOBILIER
NOVA Engineering
Key people
Filip Dierckx
Chairman of the Board · since 2024
Kristof Vande Capelle
Chief Financial Officer · since 2017
Koen Dejonckheere
Chief Executive Officer, Executive Director · since 2008
Koen Bouckaert
Managing Partner - Head Consumer · since 2020
Bart Diels
Managing Partner - Head Health and Care · since 2020
Erik Mampaey
Managing Partner - Head Sustainable Cities · since 2020
Tom Van De Voorde
Managing Partner - Head Smart Industries · since 2020
Bram Vanparys
Managing Partner - Head Life Sciences · since 2022
Edmond Bastijns
Chief Legal Officer, Secretary General · since 2016
Non-Executive Director · since 2015
Jan Desmeth
Non-Executive Director · since 2023
Marc Valentiny
Non-Executive Director · since 2024
Robert van Goethem
Non-Executive Director · since 2024
Non-Executive Independent Director · since 2018
Non-Executive Independent Director · since 2017
Non-Executive Independent Director · since 2014
Frank Verhaegen
Non-Executive Independent Director · since 2017
An Vermeersch
Non-Executive Independent Director · since 2017
Non-Executive Independent Director · since 2022
Headquarters & legal address
Karel Oomsstraat 37
Antwerpen, VAN 2018
BE
Antwerpen, VAN 2018
BE
Previous name
GIMV - INVESTERINGSMAATSCHAPPIJ VOOR VLANDEREN NV
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||